Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-24

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to understand if it is safe and useful to perform SGB (Stellate Ganglion Block) in patients who have severe lung injury Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 infection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients

NCT04445337

COVID 19 ARDS

TERMINATED PHASE1

Stellate Ganglion Block

NCT06271707

Esophagectomy Pneumonectomy Lobectomy

RECRUITING PHASE4

Ultrasound-Guided Serratus Anterior Plane Block for Additional Pain Relief After Lung Surgery

NCT04238455

Thoracic Surgery

COMPLETED PHASE2

Intraoperative Paravertebral Block and Postoperative Complications

NCT07211529

Video-assisted Thoracoscopic Surgery (VATS) Lung Cancer (Diagnosis) Pulmonary Infections +8 more

RECRUITING NA

Perioperative Diaphragm Point of Care Ultrasound

NCT03688724

Postoperative Pulmonary Complications Diaphragm Brachial Plexus Block

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Aim:

• To determine safety of stellate ganglion block (SGB) in ARDS

Secondary Aim:

* To determine efficacy of SGB in slowing the progression of ARDS

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stellate Ganglion Block (SGB)

Clinical Stellate ganglion block

Group Type EXPERIMENTAL

Stellate Ganglion Block

Intervention Type PROCEDURE

The procedure will be done at the bedside in the ICU without interfering with ongoing treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stellate Ganglion Block

The procedure will be done at the bedside in the ICU without interfering with ongoing treatment.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects age 18 to 80
* Subjects with PCR documented diagnosis of COVID-19 ARDS requiring critical care and transfer to intensive care unit
* Bilateral opacities consistent with pulmonary edema must be present and may be detected on CT or chest radiograph

Exclusion Criteria

* Subjects with pre-existing cardiac failure
* Hemodynamic Instability
* Subject on Extracorporeal membrane oxygenation (ECMO)
* Anatomical inability to do a stellate block

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No